Evidence map›Paper›PMID 33659065›Full record

ArticleAcute medicine & surgery

In-hospital mortality among patients with invasive non-group A β-hemolytic

Shoichiro Hamada, Mikio Nakajima, Richard H Kaszynski, Ryosuke Kumazawa, Hiroki Matui, Kiyohide Fushimi, Hideaki Goto, Yoshihiro Yamaguchi, Hideo Yasunaga

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Clinical microbiology reviews · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shoichiro HamadaEmergency and Critical Care Center Tokyo Metropolitan Hiroo Hospital Tokyo Japan.ORCID https://orcid.org/0000-0003-1330-8736
Mikio NakajimaEmergency and Critical Care Center Tokyo Metropolitan Hiroo Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-2903-1092
Richard H KaszynskiEmergency and Critical Care Center Tokyo Metropolitan Hiroo Hospital Tokyo Japan.
Ryosuke KumazawaDepartment of Clinical Epidemiology and Health Economics School of Public Health The University of Tokyo Tokyo Japan.
Hiroki MatuiDepartment of Clinical Epidemiology and Health Economics School of Public Health The University of Tokyo Tokyo Japan.
Kiyohide FushimiDepartment of Health Policy and Informatics Tokyo Medical and Dental University Graduate School of Medicine Tokyo Japan.
Hideaki GotoEmergency and Critical Care Center Tokyo Metropolitan Hiroo Hospital Tokyo Japan.
Yoshihiro YamaguchiDepartment of Trauma and Critical Care medicine School of Medicine Kyorin University Tokyo Japan.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics School of Public Health The University of Tokyo Tokyo Japan.
Kyorin University · JPUniversity of Tokyo Health Sciences · JPTokyo Metropolitan Hiroo Hospital · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimCombination treatment with clindamycin is recommended in patients with invasive group A

methodsThis was a nationwide retrospective cohort study using the Japanese Diagnosis Procedure Combination inpatient database focusing on the period between 2010 and 2018. We extracted data on patients diagnosed with sepsis due to non-group A β-hemolytic

resultsWe identified 3754 eligible patients during the study period. The patients were divided into the clindamycin (

conclusionsThis nationwide database study showed that combination therapy involving the use of clindamycin was not associated with lower in-hospital mortality in patients with invasive non-group A β-hemolytic

Indexed as

clindamycininvasive Streptococcus infectionStreptococcus agalactiaeStreptococcus dysgalactiae subspecies equisimilisβ‐Hemolytic Streptococcus

Identifiers

PMID33659065
PMCPMC7893999
OpenAlexW3132912611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.